A Nebraska couple whose 2-year-old son died tragically at Walt Disney World nearly five years ago wants more families to consider donating their children's organs if their child is ever facing death.
A Nebraska couple whose 2-year-old son died tragically at Walt Disney World nearly five years ago wants more families to consider donating their children's organs if their child is ever facing death.
The "Global Configure Price And Quote (CPQ) Software Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Novo Nordisk South Africa, an affiliate of the global healthcare company with more than 90 years of innovation and leadership in diabetes care, has been recently recognized as one of the best places to work in South Africa for 2021. The company received outstanding scores across several aspects of their workplace such as learning opportunities, organizational culture and giving back to the community resulting in its recognition among the employers of choice in South Africa.
The "Smart Utilities Management Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
The "Beverage Flavoring Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Vow ASA’s Annual General Meeting will be held on Friday 14 May at hrs. 09.00. The notice of the Annual General Meeting is enclosed and is also being sent to the company’s shareholders. For further queries, please contact:Erik Magelssen - CFO Tel: + 47 928 88 728 Email: firstname.lastname@example.org About Vow ASAIn Vow and our subsidiaries Scanship and Etia we are passionate about preventing pollution. Our advanced technology and world leading solutions purify wastewater and convert biomass and waste into valuable resources and generate clean energy for a wide range of industries, which as part of their own transition are looking for low carbon fuels, carbon neutral energy, decarbonised gas, and biocarbon. We have delivered technology to a wide range of industries for many years. Our solutions are scalable, standardized, patented, and thoroughly documented, and our capabilities are well proven in concrete projects and deliveries. In 2020, Vow established Vow Industries. This subsidiary will build, own, and operate plants that deliver industry decarbonisation as a service, thereby accelerating the green transition within waste and biomass valorisation and energy production. Located in Oslo, the parent company Vow ASA is listed on the Oslo Stock Exchange (ticker VOW). This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachment Vow ASA - Notice of AGM 2021
The "Global Personal Safety Tracking Devices Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Forecasts by Product Type (DNA Chip, Protein Chip, Enzyme Chip, Lab-on-a-Chip), Fabrication Techniques (Microarray, Microfluidics), Analysis Methods (Electrophoresis, Luminescence, Mass Spectrometry, Electrical Signals, Magnetism), Applications (Molecular Analysis, Diagnostics, Non-Biological Usage), End-use (Biotech & Pharma, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biochips Market Report 2020-2030" - https://www.reportlinker.com/p06058468/?utm_source=GNW PLUS Profiles of Leading Biochips Companies and COVID-19 Impact AnalysisBiochips–our new study reveals trends, R&D progress, and predicted revenues Where is the Biochips market heading? If you are involved in this sector you must read this newly updated report. This report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there. Discover how to stay ahead Our 380+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biochips Market. See how to exploit the opportunities. Forecasts to 2030 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, product profiles and commercial developments. This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today. Discover sales predictions for the world market and submarkets By Product Type • DNA Chip • Protein Chip • Enzyme Chip • Lab-on-a-Chip By Fabrication Techniques • Microarray • Microfluidics By Analysis Methods • Luminescence • Electrophoresis • Electrical Signals • Mass Spectrometry • Magnetism By Applications • Diagnostics • Molecular Analysis • Non-Biological Usage By End-Use • Biotech & Pharma • Hospitals & Diagnostics Centers • Academic & Research Institutes • Others By Region • North America – U.S. – Canada • Europe – Germany – France – UK – Italy – Spain – Rest of Europe • Asia Pacific – China – Japan – India – Rest of Asia Pacific • Latin America – Brazil – Mexico – Rest of Latin America • Middle East & Africa – GCC – South Africa – Rest of Middle East & Africa There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030. Leading companies and the potential for market growth Overall world revenue for Biochips Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead. How the Biochips Market report helps you In summary, our 380+ page report provides you with the following knowledge: • Revenue forecasts to 2030 for Biochips Market, with forecasts for Product Type, Fabrication Techniques, Analysis Methods, Applications, End-Use, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2030 for 5 regional and 14 key national markets – See forecasts for the Biochips market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. • Prospects for established firms and those seeking to enter the market– including company profiles for 9 of the major companies involved in the Biochips Market. Some of the company’s profiles in this report include Illumina, Inc., Agilent Technologies, Danaher Corporation, Fluidigm Corporation, Perkin Elmer, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KgaA, and Cellix, Ltd. Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence. Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Biochips Market and leading companies. You will find data, trends and predictions.Read the full report: https://www.reportlinker.com/p06058468/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The European Commission plans to borrow around 150 billion euros annually until 2026 to finance the bloc's unprecedented plan to make its economy greener and more digitalised, making it the biggest issuer in euros, a document from the Commission showed. The financing for the EU economic plan, agreed at 750 billion euros in 2018 prices, but totalling around 800 billion euros at current prices, would be through auctions and syndication through a primary deal network to enable regular payouts to EU governments as they complete agreed stages of projects and reforms. The Commission document said the EU executive arm would issue bonds with benchmark maturities of 3, 5, 7, 10, 15, 20, 25 and 30 years and bills below one year maturity – EU-Bills.
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Drag & Drop App Builder Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type and Application, and Geography" report has been added to ResearchAndMarkets.com's offering. According to this report the global drag & drop app builder software market was valued at US$ 790.39 million in 2019 and is projected to reach US$ 1,128.82 million by 2027; it is expected to grow at a CAGR of 4.6% from 2020 to 2027.The report highlights the key factors driving the market growth and prominent players with their developments in the market.The presence of developing economies such as India, South Korea, Malaysia, Indonesia, China, and Taiwan makes Asia a developing continent. Stable economies and technological advancements support a diversified range of industries and markets in the region. Asia is well known for technological innovations taking place in the countries mentioned above. Rapid developments, owing to technologies; initiatives from governments; and the digitalization of economies are among the factors propelling the region's overall economic growth and driving it from a developing to a developed phase. In addition, the region is characterized by vast industrialization, large population, rise in per capita GDP, and emerging economies. Further, small and medium-sized enterprises operating in the IT sector are expected to drive the market, mainly due to growing affordability of cloud-based solutions. Moreover, small and medium-sized businesses are looking to save on running costs, as even untrained professionals can build applications cost-effectively with drag & drop app builder software.Owing to decreasing prices of computer electronics and smartphones, coupled with growing penetration of broadband and wireless internet connection, the region is experiencing a digital revolution. Several industries, such as E-commerce, logistics, and media and entertainment, have witnessed exponential growth over the past 4-5 years. For instance, e-commerce players - such as Alibaba, Amazon, Flipkart, JD.com, and Meituan-Dianping - and many SMEs have been significantly benefited by penetration of the internet. Further, the strong emphasis on digitization by financial, retail, automotive, manufacturing, food & beverages industries across the region is anticipated to fuel the market. Additionally, increasing number of bloggers and SMEs in this region is expected to drive the drag & drop app builder software market in APAC.Conventional players are deploying cutting-edge technologies and coming up with innovative ideas to gain a competitive advantage over their competitors and to become successful in a long run. Moreover, the drag and drop app building platforms allow developers to create customized apps without coding requirements or with minimal hand coding, thereby helping them to accelerate the development of high-quality products, unlike the conventional life cycle of software development (SDLC). The rapid pace of digital transformation has enabled companies to meet consumer needs quickly. Reasons to Buy Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global drag & drop app builder software marketHighlights key business priorities in order to assist companies to realign their business strategiesThe key findings and recommendations highlight crucial progressive industry trends in the global drag & drop app builder software market, thereby allowing players across the value chain to develop effective long-term strategiesDevelop/modify business expansion plans by using substantial growth offering developed and emerging marketsScrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering itEnhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution Key Topics Covered: 1. Introduction1.1 Study Scope1.2 Research Report Guidance1.3 Market Segmentation2. Key Takeaways3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research4. Drag & Drop App Builder Software Market Landscape4.1 Market Overview4.2 PEST Analysis4.2.1 North America4.2.2 Europe4.2.3 Asia-Pacific4.2.4 Middle East & Africa4.2.5 South America4.3 Ecosystem Analysis4.4 Expert Opinion5. Drag & Drop App Builder Software Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increase in Internet Penetration and use of UI for App Building5.1.2 Rise in Adoption of IT Apps among SMEs5.2 Market Restraints5.2.1 Dependency on Customization Options Provided by Software Vendors5.3 Market Opportunities5.3.1 Surging Digital Transformation in IT Sector5.4 Future Trends5.4.1 Emergence of Digitization5.5 Impact Analysis of Drivers and Restraints6. Drag & Drop App Builder Software - Global Market Analysis6.1 Drag & Drop App Builder Software Market Overview6.2 Drag & Drop App Builder Software Market - Revenue, and Forecast to 2027 (US$ Million)6.3 Market Positioning - Global Market Players Ranking7. Drag & Drop App Builder Software Market Analysis - By Type7.1 Overview7.2 Drag & Drop App Builder Software Market, By Type (2019 and 2027)7.3 Cloud-based7.3.1 Overview7.3.2 Cloud-based: Drag & Drop App Builder Software Market - Revenue, and Forecast to 2027 (US$ Million)7.4 Web-based7.4.1 Overview7.4.2 Web-based: Drag & Drop App Builder Software Market - Revenue, and Forecast to 2027 (US$ Million)8. Drag & Drop App Builder Software Market Analysis - By Application8.1 Overview8.2 Drag & Drop App Builder Software Market, By Application (2019 and 2027)8.3 Large Enterprises8.3.1 Overview8.3.2 Large Enterprises: Drag & Drop App Builder Software Market - Revenue, and Forecast to 2027 (US$ Million)8.4 SMEs8.4.1 Overview8.4.2 SMEs: Drag & Drop App Builder Software Market - Revenue, and Forecast to 2027 (US$ Million)9. Drag & Drop App Builder Software Market - Geographic Analysis9.1 Overview9.2 North America: Drag & Drop App Builder Software Market9.3 Europe: Drag & Drop App Builder Software Market9.4 APAC: Drag & Drop App Builder Software Market9.5 MEA: Drag & Drop App Builder Software Market9.6 SAM: Drag & Drop App Builder Software Market10. Impact of COVID-19 Pandemic on Drag & Drop App Builder Software Market10.1 Overview10.2 North America10.3 Europe10.4 Asia-Pacific10.5 Middle East and Africa10.6 South America11. Industry Landscape11.1 Overview11.2 New Product Development12. COMPANY PROFILES12.1 Deltecs Infotech Pvt Ltd.12.1.1 Key Facts12.1.2 Business Description12.1.3 Products and Services12.1.4 Financial Overview12.1.5 SWOT Analysis12.1.6 Key Developments12.2 Salesforce.com, inc.12.2.1 Key Facts12.2.2 Business Description12.2.3 Products and Services12.2.4 Financial Overview12.2.5 SWOT Analysis12.2.6 Key Developments12.3 Thunkable, Inc.12.3.1 Key Facts12.3.2 Business Description12.3.3 Products and Services12.3.4 Financial Overview12.3.5 SWOT Analysis12.3.6 Key Developments12.4 WaveMaker, Inc.12.4.1 Key Facts12.4.2 Business Description12.4.3 Products and Services12.4.4 Financial Overview12.4.5 SWOT Analysis12.4.6 Key Developments12.5 Zoho Corporation12.5.1 Key Facts12.5.2 Business Description12.5.3 Products and Services12.5.4 Financial Overview12.5.5 SWOT Analysis12.5.6 Key Developments12.6 Mobirise12.6.1 Key Facts12.6.2 Business Description12.6.3 Products and Services12.6.4 Financial Overview12.6.5 SWOT Analysis12.6.6 Key Developments12.7 Appy Pie12.7.1 Key Facts12.7.2 Business Description12.7.3 Products and Services12.7.4 Financial Overview12.7.5 SWOT Analysis12.7.6 Key Developments12.8 Bizness Apps12.8.1 Key Facts12.8.2 Business Description12.8.3 Products and Services12.8.4 Financial Overview12.8.5 SWOT Analysis12.8.6 Key Developments12.9 BuildFire12.9.1 Key Facts12.9.2 Business Description12.9.3 Products and Services12.9.4 Financial Overview12.9.5 SWOT Analysis12.9.6 Key Developments12.10 Quixy12.10.1 Key Facts12.10.2 Business Description12.10.3 Products and Services12.10.4 Financial Overview12.10.5 SWOT Analysis12.10.6 Key Developments13. Appendix13.1 About the Publisher13.2 Word Index For more information about this report visit https://www.researchandmarkets.com/r/d5q8b1 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The South African government's downpayments to Johnson & Johnson (J&J) and Pfizer for COVID-19 vaccines are not refundable under any circumstances, its health minister said on Wednesday, describing the condition as onerous. Zweli Mkhize made the comments a day after the government suspended the rollout of J&J's vaccine, citing a recommendation by U.S. federal health agencies to pause its use because of rare cases of blood clots. The suspension is the latest setback for South Africa's efforts to immunise its population.
Super Rugby could be set for two Pacific Island teams in 2022.
All the important info around the quarter-final second leg
The "Sourcing Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeNucleus Financial Group PLC(c) Name of the party to the offer with which exempt principal trader is connected:Nucleus Financial Group PLC(d) Date dealing undertaken:13 April 2021(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?No 2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a) Purchases and sales Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/receivedOrdinaryPurchases6,687185p185p (b) Derivatives transactions (other than options) Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) Exercising Class of relevant securityProduct descriptione.g. call optionNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable) The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. 3. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:If there are no such agreements, arrangements or understandings, state “none” None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” None Date of disclosure:14/04/2021Contact name:Molly AdkinTelephone number:020 7647 8154 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at email@example.com. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
(Bloomberg) -- Zhejiang Geely Holding Group Co. is considering raising about $1 billion to help expand its iconic British sports and racing automotive business Lotus Cars into the electric vehicles market in China, according to people familiar with the matter.Geely is working with advisers to sound out potential investor interest in a funding round that could value Lotus’s EV operations at about $5 billion, the people said, asking not to be identified because the matter is private.Separately from the fundraising, the Chinese company is also weighing an initial public offering of Lotus Cars, or just the British carmaker’s EV business, as soon as next year, the people said. A listing could value the entire business, including its combustion-driven sports and racing cars, at more than $15 billion, the people said.Geely Automobile Holdings Ltd. shares rose as much as 7.6% on Wednesday in their biggest intraday gain since Jan. 26. The stock closed 5% higher, outperforming a 1.4% increase in the benchmark Hang Seng Index.Chinese billionaire Li Shufu’s Geely, which also controls Sweden-based Volvo Car AB, purchased a stake in Group Lotus in 2017. It owns 51% of the company, including both Lotus Cars and consultancy Lotus Engineering, while Malaysia’s Etika Automotive Bhd. owns the remainder, according to a press release. Under Geely, Lotus in 2019 launched its all-electric Evija hypercar, a 1,972-horsepower coupe that costs about $2 million.Considerations are ongoing and details including size and timing could change, the people said. A Geely representative declined to comment. Representatives for Lotus didn’t immediately comment when contacted by Bloomberg News.Geely is seeking to expand into electric vehicles amid a booming market in countries including China. Polestar, the electric carmaker controlled by Volvo Car and its owner Geely, is exploring options for going public as soon as this year, Bloomberg News has reported.Investor mania over EV-related stocks has pushed the share prices of players including Nio Inc. and Xpeng Inc. to stratospheric levels. That intense interest has also spawned a wave of EV upstarts raising billions and racing to list via special-purpose acquisition companies. More than $180 billion has been raised globally through SPAC IPOs in the past 12 months, Bloomberg-compiled data show.(Updates with Geely Automobile share price in fourth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Mikel Arteta says that Arsenal are “very close” to finalising a new contract with Folarin Balogun. The highly-rated academy graduate’s current Gunners deal is due to expire this summer, with clubs from Germany - including Bayer Leverkusen - keen to take advantage of his contract stand-off.
As part of our second Shop London campaign, we asked some of our favourite Londoners which independent brands they can’t enough of
Forecasts by Manufacturing Type (Outsourced, In-house), by Expression Platform (Mammalian Cell Cultures, Microbial Fermentations, Others), by Application (Vaccines, MABs, Insulin Analogues, Interferon Therapies, Human Growth Hormones, Other Therapeutic Areas) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Biological Drug API Manufacturing Companies AND COVID-19 Recovery Scenarios.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biological Drug API Manufacturing Services Market Report 2021-2031" - https://www.reportlinker.com/p06058469/?utm_source=GNW Biological Drug API Manufacturing Services Set to Witness Significant Growth Over Next 10 Years The opportunity to become a market leader in the rapidly growing biosimilar industry has spurred many companies to invest in biosimilar development, either directly or through a partnership with a more experienced CMO. Currently, in 2020, there are over 55 approved biosimilars in the EU and the market for these products is expected to grow rapidly in the coming 10 years. Demand for lower-cost biological therapies in developed and emerging markets, as well as patent expires for blockbuster biologics, will drive investment in biosimilar development. CMOs that can offer expertise and biomanufacturing capacity will benefit from contracts with biosimilar developers, such as small molecule generic drug manufacturers, as well as emerging biosimilar manufacturers looking to launch their follow-on biologics in developed markets. U.S. Holds the Maximum Market Share in Global Biological Drug API Manufacturing Services Market The US is the global leader of the biological drug API manufacturing service market and this is no surprise as it also has the highest level of demand worldwide for pharmaceuticals, including outsourced API manufacturing. Per person, the US spends around one thousand dollars a year on pharmaceuticals, higher than any other country in the world. Additionally, pharmaceuticals cost more in the US, with some drugs being twice the price they are in the UK and Canada. This is because the US government does not regulate its pharma prices. Furthermore, the opaque US health system makes it hard to draw drug-by-drug comparisons with prices abroad. The majority of the leading biotech CMOs have facilities in the United States, which provide APIs domestically. In 2020, US market accounted for US$ xx million, or over 90%, of the North American biological drug API manufacturing services revenues. Emerging markets are no longer as cheap as they used to be and additionally, emerging markets do not always meet quality standards. This deficiency in standards and rise in costs because of the demands for compliance to standards has increased the demand in the US market. Local manufacturers can also provide products more conveniently, as there are less communication or timing issues. Discover how to stay ahead Our 350+ page report provides 350+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biological Drug API Manufacturing Services Market. See how to exploit the opportunities. Forecasts to 2031 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), SWOT Analysis, product profiles and commercial developments. Discover sales predictions for the world market and sub-markets. By Manufacturing Type • Outsourced • In-house By Expression Platform • Mammalian Cell Cultures • Microbial Fermentations • Others By Application • Vaccines • MABs • Insulin Analogues • Interferon Therapies • Human Growth Hormones • Other Therapeutic Areas In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets: By Region • North America – U.S. – Canada • Europe – Germany – France – UK – Italy – Spain – Russia – Switzerland – Netherlands – Rest of Europe • Asia Pacific – China – Japan – India – Australia – South Korea – Singapore – Rest of Asia Pacific • Latin America – Brazil – Mexico – Colombia – Argentina – Rest of Latin America • Middle East & Africa – GCC – South Africa – Rest of Middle East & Africa Leading companies and the potential for market growth Overall world revenue for Biological Drug API Manufacturing Services Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead. How the Biological Drug API Manufacturing Services Market report helps you In summary, our 350+ page report provides you with the following knowledge: • Revenue forecasts to 2031 for Biological Drug API Manufacturing Services Market, with forecasts for Manufacturing Type, Expression Platform, and Application, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2031 for 5 regional and 22 key national markets– See forecasts for the Biological Drug API Manufacturing Services market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, among other prominent economies. • Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Biological Drug API Manufacturing Services Market. Some of the company’s profiled in this report include Bristol-Myers Squibb Co., Samsung Biologics, AbbVie, GSK Biopharmaceuticals, Lonza Group Ltd., NEKTAR THERAPEUTICS, Boehringer, Patheon N.V., Cytovance Biologics, and Fujifilm Diosynth Biotechnologies. Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence. Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Biological Drug API Manufacturing Services Market and leading companies. You will find data, trends, and predictions.Read the full report: https://www.reportlinker.com/p06058469/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Global Fructose Market By Product (High Fructose Corn Syrup, Fructose Syrups and Fructose Solids), By Application (Beverage, Processed Foods, Dairy Products, Bakery & Cereals, Confectionary and Other Applications), By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The Global Fructose Market size is expected to reach $6.1 billion by 2026, rising at a market growth of 8.2% CAGR during the forecast period. Fructose is a form of sweetener which is primarily utilized in the food and beverage sector. The clearest form of fructose is acquired with the help of corn or sugar processing and it is extensively utilized in the food & beverages industry. Fructose has been an important aspect of the processed food industry since the last decade.In comparison to other external sweeteners, fructose is less harmful and has encouraged as a non-caloric rising substance. Among different forms of the fructose available in the market one is the clear form fructose, generally called crystalline fructose and the other form is a blend of fructose and glucose and sold as high fructose corn syrup. The purest form of fructose is extensively utilized in baked items as it enhances its texture, quality and adds aroma to it.Increasing demand for low-sugar, low-fat, and processed low-calorie food items is anticipated to boost the growth of the industry. Fructose is a monosaccharide with a chemical formula like that of glucose but a dissimilar molecular structure. Fruits, vegetables, honey, and some plants contain fructose naturally. Fructose is utilized in food & beverages for improving their quality, taste, and texture. Moreover, the low Glycemic Index (GI) attached with the product in comparison to table sugar will probably boost its demand.By ProductBased on Product, the market is segmented into High Fructose Corn Syrup, Fructose Syrups and Fructose Solids. In 2019, the market was dominated by High fructose corn syrup with a major revenue share. These products are increasingly gaining traction due to their versatility and capacity to improve the texture, color, quality, and flavor of several foods and beverages. Besides, manufacturing companies consider high fructose corn syrup due to its liquid state, which offers an easy production process and lower costs compared to other calorie sweeteners. For example, the utilization of sugar rather than high fructose corn syrup in soft drinks expands the sweetener cost two times.By ApplicationBased on Application, the market is segmented into Beverage, Processed Foods, Dairy Products, Bakery & Cereals, Confectionary and Other Applications. The food processing application segment is expected to witness the highest CAGR during the forecast period. This is credited to the increasing technological developments and innovations coupled with the massive demand for processed food products. The increasing acceptance of packaged meals, snacks, and desserts is anticipated to fuel the fructose demand in food and beverage applications.By RegionBased on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The global fructose market was dominated by North America with a considerable revenue share in 2019. The rising acceptance of packaged beverages in the region like juices, sports drinks, and carbonated soft drinks, has encouraged the growth of the industry. On the other hand, consumers in the region are slowly shifting their focus towards organic items, which is likely to influence the product demand adversely.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Archer Daniels Midland Company, Cargill Corporation, DuPont de Nemours, Inc., Ingredion, Incorporated, Tate & Lyle PLC, Shijazhuang Huaxu Pharmaceuticals Co. Ltd., Dulcette Technologies LLC (Viachem, Inc.), Bell Chem Corp., Atlantic Chemicals Trading GmbH, and Galam Ltd.Unique Offerings from the Publisher Exhaustive coverageHighest number of market tables and figuresSubscription based model availableGuaranteed best priceAssured post sales research support with 10% customization free Key Topics Covered: Chapter 1. Market Scope & Methodology1.1 Market Definition1.2 Objectives1.3 Market Scope1.4 Segmentation1.4.1 Global Fructose Market, by Product1.4.2 Global Fructose Market, by Application1.4.3 Global Fructose Market, by Geography1.5 Methodology for the researchChapter 2. Market Overview2.1 Introduction2.1.1 Overview2.1.2 Market Composition2.2 Key Factors Impacting the Market2.2.1 Market Drivers2.2.2 Market RestraintsChapter 3. Recent Developments in Global Fructose MarketChapter 4. Global Fructose Market by Product4.1 Global High Fructose Corn Syrup Market by Region4.2 Global Fructose Syrups Market by Region4.3 Global Fructose Solids Market by RegionChapter 5. Global Fructose Market by Application5.1 Global Beverage Market by Region5.2 Global Processed Foods Market by Region5.3 Global Dairy Products Market by Region5.4 Global Bakery & Cereals Market by Region5.5 Global Confectionary Market by Region5.6 Global Other Application Market by RegionChapter 6. Global Fructose Market by Region6.1 North America Fructose Market6.2 North America Fructose Market by Application6.3 North America Fructose Market by Country6.4 Canada Fructose Market6.5 Mexico Fructose Market6.6 Rest of North America Fructose Market6.7 Europe Fructose Market6.8 Asia Pacific Fructose MarketChapter 7. Company Profiles7.1 Archer Daniels Midland Company7.1.1 Company Overview7.1.2 Financial Analysis7.1.3 Segmental and Regional Analysis7.1.4 Research & Development Expense7.1.5 Recent strategies and developments:184.108.40.206 Geographical Expansions:220.127.116.11 Partnerships, Collaborations, and Agreements:7.2 Cargill Corporation7.2.1 Company Overview7.2.2 Financial Analysis7.2.3 Regional Analysis7.2.1 Recent strategies and developments:18.104.22.168 Product Launches and Product Expansions:22.214.171.124 Geographical Expansions:7.3 DuPont de Nemours, Inc.7.3.1 Company Overview7.3.2 Financial Analysis7.3.3 Segmental and Regional Analysis7.3.4 Research & Development Expense7.4 Ingredion, Incorporated7.4.1 Company Overview7.4.2 Financial Analysis7.4.3 Regional Analysis7.4.4 Research & Development Expense7.4.5 Recent strategies and developments:126.96.36.199 Acquisition and Mergers:7.5 Tate & Lyle PLC7.5.1 Company Overview7.5.2 Financial Analysis7.5.3 Segmental Analysis7.5.4 Research & Development Expense7.5.5 Recent strategies and developments:188.8.131.52 Acquisition and Mergers:184.108.40.206 Product Launches and Product Expansions:7.6 Shijazhuang Huaxu Pharmaceuticals Co. Ltd.7.6.1 Company Overview7.7 Dulcette Technologies LLC (Viachem, Inc.)7.7.1 Company Overview7.8 Bell Chem Corp.7.8.1 Company Overview7.9 Atlantic Chemicals Trading GmbH7.9.1 Company Overview7.10. Galam Ltd.7.10.1 Company Overview7.10.2 Recent strategies and developments:220.127.116.11 Product Launches and Product Expansions: For more information about this report visit https://www.researchandmarkets.com/r/6ac1zv CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Drafting Commercial Contracts Training Course" training has been added to ResearchAndMarkets.com's offering.